ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS




Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display





 Company News
Amgen (AMGN) Submits Marketing Authorization Application For Talimogene Laherparepvec 9/2/2014 7:22:33 AM
Amgen (AMGN) Submits Marketing Authorization Application For Cholesterol-Lowering Medication Evolocumab 9/2/2014 6:57:24 AM
Amgen (AMGN) Submits BLA For Cholesterol Drug Evolocumab 8/28/2014 9:03:05 AM
Amgen (AMGN)'s Cholesterol Lowering Drug Succeeds In Phase 3 Trial 8/28/2014 8:54:31 AM
FDA Grants Amgen (AMGN) Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 8/27/2014 8:03:55 AM
Amgen (AMGN), Bristol-Myers Squibb Company (BMY) On The Prowl For Space In Crowded Cambridge, Massachusetts 8/19/2014 10:02:02 AM
Good News For Amgen (AMGN) As Parathyroid Drug AMG 416 Succeeds In Phase 3 Study 8/18/2014 3:58:43 PM
Amgen (AMGN) Recalls Nine Packaged Lots Of Aranesp 8/13/2014 4:16:18 PM
Amgen (AMGN) Drops After Hours On Failed Phase 3 Multiple Myeloma Trial 8/13/2014 4:14:02 PM
Trial A Success, Amgen (AMGN) CEO Doesn't Have To Quit 8/5/2014 6:00:19 AM
12345678910...